Oral Lymphangiomas Workup

  • Author: Sean P Edwards, DDS, MD, FRCD(C); Chief Editor: William D James, MD   more...
 
Updated: Jan 18, 2012
 

Imaging Studies

Approximately 40% of lesions are diagnosed on the basis of their clinical appearance alone; however, this observation does not obviate further imaging. Imaging plays several roles in the evaluation and treatment of oral lymphatic malformations. Imaging helps in determining the extent of the lesion and its proximity to vital structures, in determining whether the lesion contains a vascular component, and is used to assess recurrence in treated lesions.

  • Ultrasonography
    • Prenatal ultrasonography can be used to identify fetal cystic hygromas. A diagnosis of fetal cystic hygroma has important ramifications for the fetus because this lesion is often associated with major chromosomal abnormalities. However, caution is warranted with such a diagnosis because these lesions are known to regress in utero. In addition, the prenatal diagnosis of fetal cystic hygroma has an error rate as high as 70%, depending on the time of diagnosis.
    • Ultrasonography may be an invaluable tool for monitoring a lesion for regression or recurrence. Lesions will appear cystic on ultrasound, with little evidence of flow upon Doppler interrogation.
  • MRI[5]
    • Contrast-enhanced MRI is the most useful imaging modality for the assessment of lymphatic malformations.
    • The superior soft-tissue definition is critical in planning surgery and determining the extent of the lesion.
    • MRI is particularly important in distinguishing vascular malformations or mixed lesions from lymphatic malformations. Both vascular and lymphatic variants have a low signal intensity on T1-weighted images and high signal intensity on T2-weighted images. However, in contrast to vascular malformations, lymphatic variants fail to enhance after the administration of contrast material.
    • Fetal MRI is an excellent diagnostic tool for further evaluation of oral and anterior cervical lesions detected on prenatal ultrasound. It can be invaluable in determining the potential for airway obstruction and the need for ex utero intrapartum treatment (EXIT procedure) at delivery.
  • CT scanning
    • CT scans are superior to MRIs in delineating bony deformation.
    • CT scans are superior to other modalities in detecting phleboliths, which were once considered pathognomonic of venous malformations. Phleboliths observed in lymphatic malformations are most likely caused by a previous intralesional hemorrhage.
    • Three-dimensional CT scans may be obtained to permit the fabrication of stereolithographic models with which to plan orthognathic surgical correction of the maxillofacial skeletal deformity at maturity.
  • Plain radiography: Posteroanterior and lateral cephalometric radiographs are invaluable in diagnosing maxillofacial skeletal deformities secondary to lymphatic malformations.
Next

Histologic Findings

Superficial lesions consist of dilated lymph vessels lined by flat endothelial cells in a discontinuous layer immediately subjacent to the oral epithelium. These lesions often replace the dermal papillae, but they can also extend into the deeper connective tissue.

Deeper lesions consist of irregular, dilated, and interconnected lymphatic vessels, some of which reveal macroscopic cyst formation (eg, cystic hygroma, cystic lymphangioma, lymphangioma cystoides). The walls of the vessels variably contain smooth muscle bundles. Lymphoid aggregates and germinal centers can be observed in both the surrounding tissues and the walls of the lesion. Cystic spaces generally contain a lightly eosinophilic, proteinaceous fluid with scant lymphocytes.

In contrast to vascular malformations, electron microscopy and immunohistochemical techniques demonstrate irregular and fragmented basal lamina in the lymphatic malformations.

Previous
Next

Staging

  • Lymphatic malformations in the oral cavity can be classified as superficial lesions and deep lesions on the basis of their histologic and clinical features.
    • Superficial lesions include lymphangioma simplex, lymphangioma circumscriptum, and capillary hemangioma.
    • Deep lesions are further divided into microcystic variants (eg, cavernous lymphangioma) and macrocystic variants (eg, lymphangioma cystoides, cystic lymphangioma, cystic hygroma).
  • In the oral cavity, superficial and microcystic lesions are most common.
  • Below the mandible and above the maxilla, macrocystic lesions predominate.
  • Any lesion may comprise any or all of the histomorphologic variants.
  • A staging system for cervical lymphatic malformations by de Serres is based on the extent of anatomical involvement. It has been validated in terms of its ability to predict the incidence of preoperative complications, postoperative complications, long-term morbidity, and risk of recurrence, which increase with the stage of the lesion. The system is perhaps better termed a classification because staging implies a progressive neoplastic behavior.
    • Stage/class I - Unilateral infrahyoid lesions
    • Stage/class II - Unilateral suprahyoid lesions
    • Stage/class III - Unilateral suprahyoid and infrahyoid lesions
    • Stage/class IV - Bilateral suprahyoid lesions
    • Stage/class V - Bilateral suprahyoid and infrahyoid lesions
    • Stage/class VI - Bilateral infrahyoid lesions
Previous
 
 
Contributor Information and Disclosures
Author

Sean P Edwards, DDS, MD, FRCD(C)  Assistant Professor, Chief of Pediatric Oral and Maxillofacial Surgery, Section of Oral and Maxillofacial Surgery, Department of Surgery, C S Mott Children's Hospital, University of Michigan Medical Center

Sean P Edwards, DDS, MD, FRCD(C) is a member of the following medical societies: Alpha Omega Alpha, American Association of Oral and Maxillofacial Surgeons, American Cleft Palate/Craniofacial Association, American Medical Association, International Association of Oral & Maxillofacial Surgeons, and Royal College of Dentists of Canada

Disclosure: Nothing to disclose.

Coauthor(s)

Joseph Helman, DMD  Clinical Professor and Chair, Department of Oral and Maxillofacial Surgery, University of Michigan

Joseph Helman, DMD is a member of the following medical societies: American Association of Oral and Maxillofacial Surgeons

Disclosure: Nothing to disclose.

Specialty Editor Board

Smeena Khan, MD  Private Practice, Adult and Pediatric Dermatology Associates

Smeena Khan, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology

Disclosure: Nothing to disclose.

David F Butler, MD  Professor of Dermatology, Texas A&M University College of Medicine; Chair, Department of Dermatology, Director, Dermatology Residency Training Program, Scott and White Clinic, Northside Clinic

David F Butler, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, American Society for Dermatologic Surgery, American Society for MOHS Surgery, Association of Military Dermatologists, and Phi Beta Kappa

Disclosure: Nothing to disclose.

Drore Eisen, MD, DDS  Consulting Staff, Department of Dermatology, Dermatology Research Associates of Cincinnati

Drore Eisen, MD, DDS is a member of the following medical societies: American Academy of Dermatology, American Academy of Oral Medicine, and American Dental Association

Disclosure: Nothing to disclose.

Glen H Crawford, MD  Assistant Clinical Professor, Department of Dermatology, University of Pennsylvania School of Medicine; Chief, Division of Dermatology, The Pennsylvania Hospital

Glen H Crawford, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, Phi Beta Kappa, and Society of USAF Flight Surgeons

Disclosure: Nothing to disclose.

Chief Editor

William D James, MD  Paul R Gross Professor of Dermatology, Vice-Chairman, Residency Program Director, Department of Dermatology, University of Pennsylvania School of Medicine

William D James, MD is a member of the following medical societies: American Academy of Dermatology and Society for Investigative Dermatology

Disclosure: Elsevier Royalty Other

References
  1. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg. Mar 1982;69(3):412-22. [Medline].

  2. Padwa BL, Hayward PG, Ferraro NF, Mulliken JB. Cervicofacial lymphatic malformation: clinical course, surgical intervention, and pathogenesis of skeletal hypertrophy. Plast Reconstr Surg. May 1995;95(6):951-60. [Medline].

  3. Tempero RM, Hannibal M, Finn LS, Manning SC, Cunningham ML, Perkins JA. Lymphocytopenia in children with lymphatic malformation. Arch Otolaryngol Head Neck Surg. Jan 2006;132(1):93-7. [Medline].

  4. Alqahtani A, Nguyen LT, Flageole H, Shaw K, Laberge JM. 25 years' experience with lymphangiomas in children. J Pediatr Surg. Jul 1999;34(7):1164-8. [Medline].

  5. Yonetsu K, Nakayama E, Kawazu T, Kanda S, Ozeki S, Shinohara M. Value of contrast-enhanced magnetic resonance imaging in differentiation of hemangiomas from lymphangiomas in the oral and maxillofacial region. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. Oct 1999;88(4):496-500. [Medline].

  6. Puricelli E, Ponzoni D, De Paris MF, de Abreu MC, Togni L. Surgical treatment of tongue lymphangioma in a pediatric patient: a case report. J Dent Child (Chic). Jul 2011;78(2):120-3. [Medline].

  7. Bonet-Coloma C, Minguez-Martínez I, Aloy-Prósper A, Rubio-Serrano M, Peñarrocha-Diago MA, Peñarrocha-Diago M. Clinical characteristics, treatment, and evolution in 14 cases of pediatric orofacial lymphangioma. J Oral Maxillofac Surg. Jun 2011;69(6):e96-9. [Medline].

  8. Raveh E, de Jong AL, Taylor GP, Forte V. Prognostic factors in the treatment of lymphatic malformations. Arch Otolaryngol Head Neck Surg. Oct 1997;123(10):1061-5. [Medline].

  9. Aciole GT, Aciole JM, Soares LG, Santos NR, Santos JN, Pinheiro AL. Surgical treatment of oral lymphangiomas with CO2 laser: report of two uncommon cases. Braz Dent J. 2010;21(4):365-9. [Medline].

  10. Bai Y, Jia J, Huang XX, Alsharif MJ, Zhao JH, Zhao YF. Sclerotherapy of microcystic lymphatic malformations in oral and facial regions. J Oral Maxillofac Surg. Feb 2009;67(2):251-6. [Medline].

  11. Burrows PE, Mitri RK, Alomari A, et al. Percutaneous sclerotherapy of lymphatic malformations with doxycycline. Lymphat Res Biol. 2008;6(3-4):209-16. [Medline].

  12. Greinwald JH, Burke DK, Sato Y, et al. Treatment of lymphangiomas in children: an update of Picibanil (OK-432) sclerotherapy. Otolaryngol Head Neck Surg. Oct 1999;121(4):381-7. [Medline].

  13. Edwards PD, Rahbar R, Ferraro NF, Burrows PE, Mulliken JB. Lymphatic malformation of the lingual base and oral floor. Plast Reconstr Surg. Jun 2005;115(7):1906-15. [Medline].

  14. Neville DD, Damm DD, Allen CM, Bouquot JE. Soft tissue tumors. In: Oral and Maxillofacial Pathology. ed. WB Saunders Co; 1995:711.

Previous
Next
 
Marked lingual enlargement caused by lymphatic malformation. Note the pebbly surface in areas not covered by materia alba. Also note the ecchymotic lesions protruding from the buccal mucosa in the mandibular vestibules.
Note the significant left buccal and submandibular swelling.
Profile view of a young adult with oral lymphangioma (same patient as in Media File 2).
Superficial lymphatic malformation.
Superficial lymphatic malformation.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.